StonvexLoading…
StonvexStonvexStonvexCore line items from CE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.34B | $9.54B | $7.34B | $4.92B |
Operating Income | $214.00M | $-786.00M | $-879.00M | $401.00M |
Net Income | $44.00M | $-1.17B | $-1.18B | $178.00M |
EPS (Diluted) | $0.40 | $-10.64 | $-10.81 | $1.62 |
Total Assets | $21.73B | $21.70B | $22.17B | $23.71B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.76B | $1.26B | $1.44B | $1.17B |
Free Cash Flow OCF − CapEx | $10.00M | $803.00M | $635.00M | $252.00M |
Shares Outstanding | 109.98M | 109.53M | 109.50M | 109.50M |